- Home
- SPH vs OPK Comparison
SPH vs OPK Comparison
Compare SPH & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPH | OPK |
|---|---|---|
| Founded | 1945 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SPH | OPK |
|---|---|---|
| Price | $18.64 | $1.32 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $2.28 |
| AVG Volume (30 Days) | 155.1K | ★ 3.7M |
| Earning Date | 02-05-2026 | 10-29-2025 |
| Dividend Yield | ★ 7.01% | N/A |
| EPS Growth | ★ 42.10 | N/A |
| EPS | ★ 1.62 | N/A |
| Revenue | ★ $1,432,518,000.00 | $642,067,000.00 |
| Revenue This Year | $2.06 | N/A |
| Revenue Next Year | $1.64 | N/A |
| P/E Ratio | $11.44 | ★ N/A |
| Revenue Growth | ★ 7.94 | N/A |
| 52 Week Low | $16.94 | $1.11 |
| 52 Week High | $22.24 | $2.04 |
Technical Indicators
Market Signals| Indicator | SPH | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 48.35 |
| Support Level | $18.54 | $1.29 |
| Resistance Level | $18.90 | $1.34 |
| Average True Range (ATR) | 0.32 | 0.05 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 38.03 | 38.44 |
Price Performance
Historical ComparisonAbout SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.